Evidence map›Paper›PMID 29069284›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Molecular Epidemiology of Tuberculosis in British Columbia, Canada: A 10-Year Retrospective Study.

Jennifer L Guthrie, Clare Kong, David Roth, Danielle Jorgensen, Mabel Rodrigues, Linda Hoang, Patrick Tang, Victoria Cook, James Johnston, Jennifer L Gardy

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Genetic Diversity and Molecular Epidemiology ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. ComparingEpidemiology and infection · 2023
    Article
  6. Pathogens (Basel, Switzerland) · 2022
    Review
  7. Insights into the Complexity of a DormantMicrobiology spectrum · 2022
    Article
  8. Article
  9. Article
  10. Using Whole-genome Sequencing to Determine the Timing of Secondary Tuberculosis in British Columbia, Canada.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. The Interplay of Human andFrontiers in genetics · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jennifer L GuthrieSchool of Population and Public Health, University of British Columbia.
Clare KongBritish Columbia Centre for Disease Control Public Health Laboratory.
David RothBritish Columbia Centre for Disease Control.
Danielle JorgensenBritish Columbia Centre for Disease Control Public Health Laboratory.
Mabel RodriguesBritish Columbia Centre for Disease Control Public Health Laboratory.
Linda HoangBritish Columbia Centre for Disease Control Public Health Laboratory.
Patrick TangDepartment of Pathology, Sidra Medical and Research Center, Doha, Qatar.
Victoria CookBritish Columbia Centre for Disease Control.
James JohnstonBritish Columbia Centre for Disease Control.
Jennifer L GardySchool of Population and Public Health, University of British Columbia.

Funding

CIHR
6 · The paper itself

Abstract

Background: Understanding regional molecular epidemiology allows for the development of more efficient tuberculosis prevention strategies in low-incidence settings. Methods: We analyzed 24-locus mycobacterial interspersed repetitive-unit-variable-number tandem repeat (MIRU-VNTR) genotyping for 2290 Mycobacterium tuberculosis clinical isolates collected in the province of British Columbia (BC), Canada, in 2005-2014. Laboratory data for each isolate were linked to case-level clinical and demographic data. These data were used to describe the molecular epidemiology of tuberculosis across the province. Results: We detected >1500 distinct genotypes across the 4 major M. tuberculosis lineages, reflecting BC's diverse population. Disease site and clustering rates varied across lineages, and MIRU-VNTR was used to group the 2290 isolates into 189 clusters (2-70 isolates per cluster), with an overall clustering rate of 42.4% and an estimated local transmission rate of 34.1%. Risk factors for clustering varied between Canadian-born and foreign-born individuals; the former had increased odds (odds ratio, 7.8; 95% confidence interval [CI], 6.2-9.6) of belonging to a genotypic cluster, although nearly one-quarter of clusters included both Canadian- and foreign-born persons. Large clusters (≥10 cases) occurred more frequently within the M. tuberculosis Euro-American lineage, and individual-level risk factors associated with belonging to a large cluster included being Canadian born (adjusted odds ratio, 3.3; 95% CI, 2.3-4.8), residing in a rural area (2.3; 1.2-4.5), and illicit drug use (2.0; 1.2-3.4). Conclusions: Although tuberculosis in BC largely arises through reactivation of latent tuberculosis in foreign-born persons, locally transmitted infections occur in discrete populations with distinct disease and risk factor profiles, representing groups for targeted interventions.

Indexed as

GenotypeAdolescentAdultAgedBacterial Typing TechniquesBritish ColumbiaChildChild, PreschoolDNA, BacterialFemaleHumansInfantInfant, NewbornMaleMiddle AgedMinisatellite RepeatsDNA, Bacterial

Identifiers

PMID29069284
PMCPMC5850024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.